For the Inventor, By the Inventor

Enter assignee name

Charlestown, MA, United States of America

Selux Diagnostics, Inc.

USPTO Granted Patents = 19

% Expired Patents = 5.3

EPO Patents = 2

Trademarks = 2

Forward Citations = 44

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Eric D Stern (16 out of 24 patents)

Kelly Flentie (14 out of 15 patents)

Aleksandar Vacic (11 out of 15 patents)

4. Benjamin Spears (5 out of 5 patents)

5. Nathan Purmort (4 out of 4 patents)

6. Alec Nathanson Flyer (4 out of 13 patents)

7. Frederick P Floyd, Jr (2 out of 2 patents)

8. Nicholas Phelan (2 out of 2 patents)

9. Ronan Hayes (2 out of 3 patents)

10. Anna Passernig (2 out of 2 patents)

11. Paul Otten (2 out of 2 patents)

12. Randy Tragni (2 out of 2 patents)

13. Andriy Tsupryk (2 out of 2 patents)

14. Bruce J Richardson (2 out of 60 patents)

15. Frederick P Floyd (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 12312632 - Systems and methods for performing antimicrobial susceptibility testing (2025-05-27),

2. 12203124 - Methods for improved rapid antimicrobial susceptibility testing (2025-01-21),

3. 12129510 - System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples (2024-10-29),

4. 11866763 - System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples (2024-01-09),

5. 11845976 - Systems and methods for performing antimicrobial susceptibility testing (2023-12-19),

6. 11835523 - Assays for improving automated antimicrobial susceptibility testing accuracy (2023-12-05),

7. 11828766 - Performing antimicrobial susceptibility testing and related systems and methods (2023-11-28),

8. 11649477 - Assays and reagents for antimicrobial susceptibility testing (2023-05-16),

9. 11390900 - Antimicrobial cartridges and processes for multiplexed antimicrobial susceptibility testing (2022-07-19),

10. 11339418 - Antimicrobial susceptibility testing and microbial identification (2022-05-24),

11. 11287436 - Carrier for automated microbiology sample processing (2022-03-29),

12. 11268960 - Assays for improving automated antimicrobial susceptibility testing accuracy (2022-03-08),

13. 11268126 - System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples (2022-03-08),

14. 10982254 - Methods for rapid antimicrobial susceptibility testing (2021-04-20),

15. D911546 - Apparatus for medical or laboratory diagnosis (2021-02-23),

Company Overview

Selux Diagnostics, Inc. is a biotechnology company based in Charlestown, MA, specializing in advanced diagnostic solutions for infectious diseases. The company focuses on developing innovative technologies that enhance the speed and accuracy of pathogen identification and antibiotic susceptibility testing. By leveraging cutting-edge molecular techniques, Selux aims to improve patient outcomes and support healthcare providers in making informed treatment decisions, ultimately contributing to the fight against antibiotic resistance.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#2 in Charlestown, MA

#1,049 in Massachusetts

#17,138 in US

#32,663 in the World

Charlestown, MA, United States of America

Selux Diagnostics, Inc.

Forward Citations = 44

21 inventors:

Eric D Stern (16 out of 24 patents)

Kelly Flentie (14 out of 15 patents)

Aleksandar Vacic (11 out of 15 patents)

4. Benjamin Spears (5 out of 5 patents)

5. Nathan Purmort (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Selux Diagnostics, Inc.. Retrieved from https://idiyas.com/company/selux-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…